Effect of Rosa damascena on nonalcoholic fatty liver disease

Phase 2

Recruiting

• Conditions: on Alcoholic Fatty Liver Disease.; Non Alcoholic Fatty Liver Disease; k76.0

• Registration Number: IRCT20191006044994N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Sonographic report of Grade 1- 2-3 fatty liver
Increase in ALT> 38? Increase in AST>31 Ages 12 to 80 years
Ages 18 to 80 years

Exclusion Criteria

The patient's unwillingness to participate in the scheme
Pregnancy & lactation
Anti coagulant drugs consumption
Thyroid diseases
Spleen diseases
Cirrhosis ,viral hepatitis and obstructive liver disese
Treated dyslipidemia
Overt Diabetes mellitus
Lung diseases
Taking any medication that affects liver metabolism and enzymes, including oral contraceptives, corticosteroids, salazines, etc.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Alt(Alanin transaminase). Timepoint: Onset and 12th week of study(End of study). Method of measurement: Hitachi-912 biochemistery instrument.;Ast(Aspartate transaminase). Timepoint: Onset and 12th week of study(End of study). Method of measurement: Hitachi-912 biochemistery instrument.